News
A 35-year-old man presents with a chief complaint of purple discoloration of his toes and associated skin lesions that have ...
Objective Combination therapy with rituximab and belimumab is a novel treatment strategy for severe SLE and lupus nephritis. Phase II studies have shown promising results, although long-term data are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results